Jason Amello
Director of Finance/CFO chez TSCAN THERAPEUTICS, INC.
Fortune : 319 174 $ au 31/03/2024
Profil
Jason A.
Amello is a Trustee at New England Baptist Hospital and the Chief Financial Officer at TScan Therapeutics, Inc. He previously worked as a Director at Opexa Therapeutics, Inc., an Independent Director at Acer Therapeutics, Inc., the Chief Accounting Officer, Senior VP & Controller at Genzyme Corp., and a Senior Manager at Deloitte LLP (New York).
He also served as the Chief Financial Officer, Treasurer & Executive VP at Alaunos Therapeutics, Inc., the Treasurer, Chief Financial & Accounting Officer at Akebia Therapeutics, Inc., and the Chief Financial & Accounting Officer at Candel Therapeutics, Inc. Additionally, he was the Chief Financial Officer at Saniona AB.
Amello received his undergraduate degree from Boston College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/11/2023 | 202 009 ( 0,70% ) | 319 174 $ | 31/03/2024 |
Postes actifs de Jason Amello
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director of Finance/CFO | 29/01/2024 |
New England Baptist Hospital
 New England Baptist Hospital Hospital/Nursing ManagementHealth Services New England Baptist Hospital provides orthopedic surgery and the treatment of musculoskeletal diseases and disorders. Its services include orthopedics, general surgery, medical services, patient care services, and programs. The company was founded by Francis Fremont Whittier in 1893 and is headquartered in Boston, MA. | Director/Board Member | - |
Anciens postes connus de Jason Amello
| Sociétés | Poste | Fin |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Director of Finance/CFO | 12/01/2024 |
| ACER THERAPEUTICS INC. | Director/Board Member | 17/11/2023 |
| SANA AB | Director of Finance/CFO | 01/09/2022 |
| AKEBIA THERAPEUTICS, INC. | Director of Finance/CFO | 29/06/2020 |
| ALAUNOS THERAPEUTICS, INC. | Director of Finance/CFO | 31/05/2013 |
Formation de Jason Amello
| Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| SANA AB | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Commercial Services |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
New England Baptist Hospital
New England Baptist Hospital Hospital/Nursing ManagementHealth Services New England Baptist Hospital provides orthopedic surgery and the treatment of musculoskeletal diseases and disorders. Its services include orthopedics, general surgery, medical services, patient care services, and programs. The company was founded by Francis Fremont Whittier in 1893 and is headquartered in Boston, MA. | Health Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
